Troy A. McEachron, Ph.D.
Affiliations: | 2011 | Pathology | University of North Carolina, Chapel Hill, Chapel Hill, NC |
Area:
Pathology, Molecular BiologyGoogle:
"Troy McEachron"Parents
Sign in to add mentor| Frank C. Church | grad student | 2011 | UNC Chapel Hill | |
| (Regulation of urokinase plasminogen activator and plasminogen activator inhibitor-1 in murine breast cancer cells.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Mannheimer JD, Tawa G, Gerhold D, et al. (2023) Transcriptional profiling of canine osteosarcoma identifies prognostic gene expression signatures with translational value for humans. Communications Biology. 6: 856 |
| Hingorani P, Dinu V, Zhang X, et al. (2020) Transcriptome analysis of desmoplastic small round cell tumors identifies actionable therapeutic targets: a report from the Children's Oncology Group. Scientific Reports. 10: 12318 |
| Gibbs LD, Williams SR, Weisenfeld NI, et al. (2020) Abstract A087: Spatial RNA-seq reveals intratumor heterogeneity and transcriptional substructure in a diverse cohort of high-grade ovarian cancers Cancer Epidemiology, Biomarkers & Prevention. 29 |
| Gibbs LD, Byun J, Yan T, et al. (2020) Abstract B055: Characterization of immune cell subsets from tissue expression profiles in African American triple-negative breast cancer patients Cancer Epidemiology, Biomarkers & Prevention |
| Sorenson L, McEachron TA. (2020) Abstract A77: Targeting lymphocyte exclusion in metastatic osteosarcoma Cancer Research. 80 |
| Gibbs LD, Williams SR, Weisenfeld NI, et al. (2020) Abstract NG03: Spatial RNA-seq reveals intratumor heterogeneity and transcriptional substructure in high-grade ovarian cancers Tumor Biology |
| Sadeghi S, Hether T, Yeon J, et al. (2020) 455 Impact of EphB4 and PD-1 treatment on immune infiltrate in advanced bladder cancer Journal For Immunotherapy of Cancer. 8: A482-A482 |
| Sorenson L, Fu Y, Hood T, et al. (2019) Targeted transcriptional profiling of the tumor microenvironment reveals lymphocyte exclusion and vascular dysfunction in metastatic osteosarcoma. Oncoimmunology. 8: e1629779 |
| Gibbs LD, Qian J, Webb M, et al. (2019) Abstract 4703: Single Cell CNV End to End workflow to uncover tumor heterogeneity in a murine breast cancer model Cancer Research. 79: 4703-4703 |
| McEachron TA, Triche TJ, Sorenson L, et al. (2018) Profiling targetable immune checkpoints in osteosarcoma. Oncoimmunology. 7: e1475873 |